GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients

Carcinogenesis

Volumn 21, Issue 1, 2000, Pages 49-54

  Hou, Sai Mei ^a   Ryberg, David ^b   Fält, Susann ^a   Deverill, An ^b   Tefre, Toril ^c   Børresen, Anne Lise ^d   Haugen, Aage ^b   Lambert, Bo ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; DRUG METABOLIZING ENZYME; GLUTATHIONE TRANSFERASE; GST M1; NAT2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; GENOTYPE; HUMAN; LARGE CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; NORWAY; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA;

EID: 0033967669     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.1.49     Document Type: Article

References (30)

1. D'Errico, A., Taioli, E., Chen, X. and Vineis, P. (1996) Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1, 149-173.
2. Seidegård, J., Pero, R.W., Markowitz, M.M., Roush, G., Miller, D.G. and Beattie, E.J. (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
3. McWilliams, J.E., Sanderson, B.J., Harris, E.L., Richert-Boe, K.E. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 4, 589-594.
4. Nazar-Stewart, V., Motulsky, A.G., Eaton, D.L., White, E., Hornung, S.K., Leng, Z.T., Stapleton, P. and Weiss, N.S. (1993) The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53, 2313-2318.
5. Anttila, S., Luostarinen, L., Hirvonen, A., Elovaara, E., Karjalainen, A., Nurminen, T., Hayes, J.D., Vainio, H. and Ketterer, B. (1995) Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking and asbestos exposure. Cancer Res., 55, 3305-3309.
6. Nakajima, T., Elovaara, E., Anttila, S., Hirvonen, A., Camus, A.M., Hayes, J.D., Ketterer, B. and Vainio, H. (1995) Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis, 16, 707-711.
7. Inskip, A., Elexperu-Camiruaga, J., Buxton N., Dias, P.S., MacIntosh, J., Campbell, D., Jones, P.W., Yengi, L., Talbot, J.A., Strange, R.C. and Fryer, A.A. (1995) Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem. J., 312, 713-716.
8. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S. and Vainio, H. (1993) The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis, 14, 1479-1481.
9. Alexandrie, A.K., Sundberg, M.I., Seidegård, J., Tomling, G. and Rannug, A. (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-1790.
10. Kihara, M., Noda, K. and Kihara, M. (1995) Distribution of GSTMI null genotype in relation to gender, age and smoking status in Japanese lung cancer patients. Pharmacogenetics, 5, 74-79.
11. London, S.J., Daly, A.K., Cooper, J., Navidi, W.C., Carpenter, C.L. and Idle, J.R. (1995) Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles county, California. J. Natl Cancer Inst., 87, 1246-1253.
12. Goto, I., Yoneda, S., Yamamoto, M. and Kawajiri, K. (1996) Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer Res., 56, 3725-3730.
13. Lear, J.T., Heagerty, A.H., Smith, A., Bowers, B., Payne, C.R., Smith, C.A., Jones, P.W., Gilford, J., Yengi, L., Alldersea, J., Fryer, A.A. and Strange, R.C. (1996) Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTMI, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis, 17, 1891-1896.
14. Fontana, X., Peyrottes, I., Rossi, C., Leblanc-Talent, P., Ettore, F., Namer, M. and Bussiere, F. (1988) Study of the frequencies of CYP1A1 gene polymorphisms and glutathione transferase mul gene in primary breast cancers: an update with an additional 114 cases. Mutat. Res., 403, 45-53.
15. Vatsis, K.P., Weber, W.W., Bell, D.A., Dupret, J.M., Evans, D.A., Grant, D.M., Hein, D.W., Lin, H.J., Meyer, U.A., Relling, M.V., Sim, E., Suzuki, T. and Yamazoe, Y. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-17.
16. Cascorbi, I., Drakoulis, N., Brockmoller, J., Maurer, A., Sperling, K. and Roots, I. (1995) Arylamine N-acelyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet., 57, 581-592.
17. Ambrosone, C.B., Freudenheim, J.L., Graham, S., Marshall, J.R., Vena, J.E., Brasure, J.R., Michalek, A.M., Laughlin, R., Nemoto, T., Gillenwater, K.A. and Shields, P.G. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk. J. Am. Med. Assoc., 276, 1494-1501.
18. Martinez, C., Agundez, J.A.G., Olivera, M., Martin, R., Ladero, J.M. and Benitez, J. (1995) Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics, 5, 207-214.
19. Cascorbi, I., Brockmoller, J., Mrozikiewicz, P.M., Bauer, S., Loddenkemper, R. and Roots, I. (1996) Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res., 56, 3961-3966.
20. Oyama, T., Kawamoto, T., Mizoue, T., Yasumoto, K., Kodama, Y. and Mitsudomi, T. (1997) N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res., 17, 577-581.
21. Hirvonen, A., Pelin, K., Tammilehto, L., Karjalainen, A., Mattson, K. and Linnainmaa, K. (1995) Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res., 55, 2981-2983.
22. Hirvonen, A., Saarikoski, S.T., Linnainmaa, K., Koskinen, K., Husgafvel-Pursiainen, K., Mattson, K. and Vainio, H. (1996) Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl Cancer Inst., 88, 1853-1856.
23. Tefre, T., Daly, A.K., Armstrong, M., Leathart, J.B., Idle, J.R., Brogger, A. and Borresen, A.L. (1994) Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls. Pharmacogenetics, 4, 47-57.
24. Ryberg, D., Skaug, V., Hewer, A., Phillips, D.H., Harries, L.W., Wolf, C.R., Ogreid, D., Ulvik, A., Vu, P. and Haugen, A. (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285-1289.
25. Nyberg, F., Hou, S.-M., Hemminki, K., Lambert, B. and Pershagen, G. (1998) Glutathione S-transferase μ1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol. Biomarkers Prev., 7, 875-883.
26. Ryberg, D., Kure, E., Lystad, S., Skaug, V. Stangeland, L., Mercy, I., Børresen, A.L. and Haugen, A. (1994) p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res., 54, 1551-1555.
27. Hickman, D., Risch, A., Camilleri, J.P. and Sim, E. (1992) Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics, 2, 217-226.
28. Begg, C.B. and Zhang, Z. (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol. Biomarkers Prev., 3, 173-175.
29. Lang, N.P. and Kadlubar, F.F. (1991) Aromatic and heterocyclic amine metabolism and phenotyping in humans. Prog. Clin. Biol. Res., 372, 33-47.
30. Bouchardy, C., Mitrunen, K., Wikman, H., Husgafvel-Pursiainen, K., Dayer, P., Benhamou, S. and Hirvonen, A. (1998) N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics, 8, 291-298.